Turk, HMKocyigit, AAliyev, ACelik, RSSeker, MESUTCoban, EDemir, TBaydas, T2020-02-022020-02-022019-07-29Turk H., Aliyev A., Celik R., Seker M., Coban E., Demir T., Baydas T., Kocyigit A., -Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer.-, Current problems in cancer, ss.100497, 2019https://openaccess.bezmialem.edu.tr/handle/20.500.12645/14046Objective: M30 and M65 levels reflect tumor cell activity in patients with epithelial cancer. Cytokeratin 18 is one of the cell skeletal elements. M30 is a apoptotic marker of cytokeratin 18. M65 levels are both an apoptosis and a necrosis marker. The aim of our study was to determine the predictive value of M30 and M65 levels in neoadjuvant treatment of breast cancer.Article8506984474910.1016/j.currproblcancer.2019.06.00931371034